Whereas several recent studies have performed head‐to‐head assessments of the diagnostic performance between different plasma biomarkers and amyloid‐ and tau‐PET imaging [35, 36, 37, 38], our study compared the performance of plasma p‐tau biomarker with the metabolic patterns associated with AD. Here, MAPT is linked to Alzheimer disease.